Health Condition 1: B354- Tinea corporis
Conditions
Interventions
Intervention1: Nixoderm Tin: Product to be applied twice a day at the site of infected area, duration-30 days
Dosage form : Cream
Control Intervention1: Placebo: Product to be applied twice a day at
Sponsors
M/s.SC Johnson & Son Nigeria Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1.Male and Female participants 2.Aged between 18-65 years. 3.Diagnosed with tenia corporis infection 4.Willing to give Informed Consent. 5.Willing to complete the study assessments/questionnaires. 6.Willing to avoid usage of his/her own skin care products in controlling tenia corporis infection for at least one week before the commencement and during this study.
Exclusion criteria
Exclusion criteria: 1. Pregnancy or breast feeding. 2. Participants with the history of hypersensitivity to skin care products. 3. Participants with mild to severe anaphylaxis reaction. 4. Participants with pre existing severe systemic disease necessitating longterm medication. 5. Participants with any other concomitant skin diseases such as psoriasis eczema etc. 6. Evidence of significant uncontrolled comorbid disease which in the investigators opinion would jeopardize patient participation. 7. History of cancer, including solid tumors hematologic malignancies and carcinoma in situ. 8. Participation in the current or previous clinical trial with any approved or investigational products during the past 1 month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Percentage reduction in ringworm infection from baseline to all study visits to be evaluated by following parameters: KOH preparation of fungus Dermatological Assessments Percentage reduction in itching and scaling from baseline to all study visits by Visual Analogue Scores.Timepoint: Screening, Day 15 and Day 30 | — |
Secondary
| Measure | Time frame |
|---|---|
| The safety of Nixoderm Tin in tenia corporis infection from baseline to all study visits is determined by evaluating adverse eventsTimepoint: Day 0,Day 15 and Day 30 | — |
Countries
India
Contacts
Public ContactDr Ashok Godavarthi
Radiant Research Services PVT LTD.
Outcome results
None listed